| ROK |
Report |
Adjusted EPS (Q3 FY26) |
BEAT |
pred ~$3.52 vs. cons $3.38 |
HIGH |
| ROK |
Report |
Revenue (Q3 FY26) |
BEAT |
pred ~$2.29B vs. cons $2.25B |
MEDIUM |
| ROK |
Report |
Enterprise Operating Margin (Q3 FY26) |
IN-LINE |
pred ~22.6% vs. cons 22.4% |
MEDIUM |
| ROK |
Guide |
FY2026 Adjusted EPS guidance |
BETTER |
guide ~$13.10 (midpoint of raised $12.90-$13.30) vs. cons $13.00 (FY2026) |
MEDIUM |
| ROK |
Guide |
FY2026 Organic/Reported Sales growth guidance |
BETTER |
guide ~7.5% (midpoint of raised 6%-9% range) vs. cons ~7.0% (FY2026) |
LOW |
| ROK |
Guide |
Q4 FY2026 implied Enterprise Operating Margin/EPS commentary |
BETTER |
guide ~23.0% margin / ~$3.75 EPS vs. cons ~22.7% margin / ~$3.70 EPS (Q4 FY2026) |
LOW |
| ROK |
Return |
Day-1 residual (stock − beta × S&P 500) |
+1.5% |
— |
MEDIUM |
| ROK |
Return |
5-day cumulative residual |
-0.8% (FADE) |
Stock has already rallied ~18% since the Q2 beat-and-raise and trades near 42x earnings, so a Q3 beat that merely confirms management's own sequential guidance (flat sales, +$0.05 EPS) rather than showing fresh acceleration risks a 'sell the news' fade as analysts roll Q4 estimates only modestly higher (implicit out-period math already embeds most of the good news); memory/component inflation commentary and a Software & Control margin step-down from Q2's 34.9% high-water mark could also cap upward revisions, pulling the initial pop back over the following days. |
MEDIUM |